Tenax Therapeutics (TENX) Other Non-Current Liabilities (2012 - 2019)
Tenax Therapeutics (TENX) posted quarterly Other Non-Current Liabilities of $8775.0 for Q4 2019, down 31.08% year-over-year from $12732.0 in Q4 2018, and down 31.08% on a QoQ basis from $12732.0 in Q4 2018.
Tenax Therapeutics (TENX) Other Non-Current Liabilities (2012 - 2019) Analysis & Trends
Tenax Therapeutics has reported Other Non-Current Liabilities for 7 years, with the latest figure at $8775.0 in Q4 2019.
- Other Non-Current Liabilities for Q4 2019 came in at $8775.0, down 31.08% year-over-year; the trailing twelve-month figure through Dec 2019 was $8775.0 (down 31.08% YoY), and the FY2019 annual result was $8775.0, down 31.08% from the prior year.
- Other Non-Current Liabilities eased to $8775.0 in Q4 2019, from $12732.0 in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $572445.0 in Q2 2015 and troughed at $8775.0 in Q4 2019.
- A 5-year average of $163897.9 and a median of $48322.5 in 2017 frame the typical range for Other Non-Current Liabilities.
- The widest annual swing landed in 2017, when Other Non-Current Liabilities plunged 88.37%; it then sank 31.08% in 2019.
- A 5-year view of Other Non-Current Liabilities shows it stood at $524340.0 in 2015, then tumbled by 56.88% to $226092.0 in 2016, then plunged by 81.72% to $41325.0 in 2017, then sank by 69.19% to $12732.0 in 2018, then tumbled by 31.08% to $8775.0 in 2019.
- Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $8775.0 in Q4 2019, $12732.0 in Q4 2018, and $19376.0 in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Tenax Therapeutics | 78.47 Mn | 78.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 8,775.00 |
| Dec 31, 2018 | 12,732.00 |
| Sep 30, 2018 | 19,376.00 |
| Jun 30, 2018 | 24,551.00 |
| Mar 31, 2018 | 20,700.00 |
| Dec 31, 2017 | 33,673.00 |
| Sep 30, 2017 | 36,078.00 |
| Jun 30, 2017 | 72,157.00 |
| Mar 31, 2017 | 55,320.00 |
| Dec 31, 2016 | 226,092.00 |
| Sep 30, 2016 | 310,275.00 |
| Jun 30, 2016 | 370,405.00 |
| Dec 31, 2015 | 524,340.00 |
| Apr 30, 2015 | 572,445.00 |
| Apr 30, 2013 | 54,660.00 |
| Jan 31, 2013 | 65,592.00 |
| Oct 31, 2012 | 76,524.00 |